Pharmacokinetics of favipiravir in adults with mild COVID-19 in Thailand
Weerawat Manosuthi, Ing-orn Prasanchaimontri, Suvimol Niyomnaitham, Rujipas Sirijatuphat, Lantharita Charoenpong, Katherine Copeland, Tim R. Cressey, Phongpan Mokmued, View ORCID ProfileKulkanya Chokephaibulkit
doi: https://doi.org/10.1101/2022.03.09.22271220
Weerawat Manosuthi
aBamrasnaradura Infectious Diseases Institute, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand
Ing-orn Prasanchaimontri
bBureau of Drug and Narcotic, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand
Suvimol Niyomnaitham
cDepartment of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
dSiriraj Institute of Clinical Research (SICRES), Mahidol University, Thailand
Rujipas Sirijatuphat
eDepartment of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Lantharita Charoenpong
aBamrasnaradura Infectious Diseases Institute, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand
Katherine Copeland
fMahidol University International College, Salaya, Nakhon Pathom, Thailand
Tim R. Cressey
gAMS-IRD collaboration, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand
hDepartment of Molecular & Clinical Pharmacology, University of Liverpool, UK
Phongpan Mokmued
iDivision of Genomics Medicine and Innovation Support, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand
Kulkanya Chokephaibulkit
dSiriraj Institute of Clinical Research (SICRES), Mahidol University, Thailand
jDepartment of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
Article usage
Posted March 12, 2022.
Pharmacokinetics of favipiravir in adults with mild COVID-19 in Thailand
Weerawat Manosuthi, Ing-orn Prasanchaimontri, Suvimol Niyomnaitham, Rujipas Sirijatuphat, Lantharita Charoenpong, Katherine Copeland, Tim R. Cressey, Phongpan Mokmued, Kulkanya Chokephaibulkit
medRxiv 2022.03.09.22271220; doi: https://doi.org/10.1101/2022.03.09.22271220
Pharmacokinetics of favipiravir in adults with mild COVID-19 in Thailand
Weerawat Manosuthi, Ing-orn Prasanchaimontri, Suvimol Niyomnaitham, Rujipas Sirijatuphat, Lantharita Charoenpong, Katherine Copeland, Tim R. Cressey, Phongpan Mokmued, Kulkanya Chokephaibulkit
medRxiv 2022.03.09.22271220; doi: https://doi.org/10.1101/2022.03.09.22271220
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2302)
- Dermatology (205)
- Emergency Medicine (372)
- Epidemiology (11640)
- Forensic Medicine (10)
- Gastroenterology (686)
- Genetic and Genomic Medicine (3640)
- Geriatric Medicine (342)
- Health Economics (625)
- Health Informatics (2337)
- Health Policy (921)
- Hematology (337)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3395)
- Nursing (193)
- Nutrition (512)
- Oncology (1784)
- Ophthalmology (528)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6037)
- Radiology and Imaging (1238)
- Respiratory Medicine (815)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (144)